BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

British Journal of Radiology (2004) 77, 847-850
© 2004 British Institute of Radiology
doi: 10.1259/bjr/88840344

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mazonakis, M
Right arrow Articles by Gourtsoyiannis, N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mazonakis, M
Right arrow Articles by Gourtsoyiannis, N

Full Paper

Therapeutic external irradiation in women of reproductive age: risk estimation of hereditary effects

M Mazonakis, MSc, PhD 1 J Damilakis, MSc, PhD 1 H Varveris, MD, PhD 2 and N Gourtsoyiannis, MD, PhD 3

Departments of 1 Medical Physics, 2 Radiotherapy & Oncology and 3 Radiology, University Hospital of Iraklion, PO Box 1352, 71110 Iraklion, Crete, Greece

Exposure of women of childbearing age to ionizing radiation may result in induction of genetic disorders in future generations. This study aims to estimate the risk of hereditary effects attributable to therapeutic external irradiation in women. An anthropomorphic phantom was used to simulate radiotherapy in female patients and ovarian dose was measured for irradiation of brain, breast and lung cancer, and for treatment of Hodgkin's disease. These malignancies are among the most common tumours presenting in women of reproductive age. Dose measurements were undertaken using thermoluminescent dosemeters and all exposures were made with 6 MV X-ray beams. The dose to ovaries was found to be 2–3 cGy, 8–11 cGy and 11–15 cGy depending on the distance from the primary irradiation field during radiotherapy of brain, breast and lung cancer, respectively. The corresponding ovarian dose resulting from treatment of supradiaphragmatic and infradiaphragmatic Hodgkin's disease was 18–25 cGy and 128–356 cGy, respectively. A small excess risk of genetic diseases of (1–15) x 10–4 was estimated for radiotherapy above the diaphragm. Pelvic irradiation resulted in an increased risk of hereditary effects of (77–214) x 10–4.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2004 by the British Institute of Radiology.